Delivery Order SPE2DB22D1106-SPE2DB25FFHY2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units) with a ceiling value of $12,939.63. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is set to be completed by April 30, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $3,379.08 delivery order to AmerisourceBergen Drug Corp for Trokendi XR 100 mg capsules (30-count) on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. Trokendi XR is a brand-name neurological medication used primarily for...
- The Defense Logistics Agency awarded a delivery order valued at $1,966.96 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania facility. Trokendi XR is a branded anticonvulsant medication commonly used for seizure management and migraine prevention...
- The Defense Logistics Agency awarded a delivery order valued at $6,417.22 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 200 mg capsules (30-count) on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,392.42. This non-set-aside award represents a competitively awarded delivery order for pharmaceutical products supporting federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Trokendi XR 50 mg capsules (30-count) with a ceiling value of $10,882.14. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Trokendi XR 25 mg capsules (30-count) valued at $1,476.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by May 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,727.33 for Trokendi XR 100 mg capsules (30-count) under a firm fixed-price contract type. This delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-set-aside award made through competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,833.96 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) on August 13, 2025. This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 14, 2025. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trokendi XR 200 mg capsules (30-count) with a ceiling value of $2,107.48. The contract utilizes firm fixed pricing and is classified as a non-set-aside award, indicating it was competitively awarded through open procurement processes. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 23, 2025. This...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHY2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Trokendi XR 100 mg capsules (30-count) with a contract ceiling value of $5,466.97. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trokendi XR is a branded anticonvulsant medication used in the treatment of seizure disorders and migraine prevention, representing part of the company's broader pharmaceutical supply portfolio for federal military and healthcare systems. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime IDC vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates consistent capability in fulfilling competitive pharmaceutical procurement requirements across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 9/9/25 |